Focus: IQVIA is the world's largest contract research organization (CRO) with 93,000 employees, providing clinical trial management, data analytics, and regulatory services to pharmaceutical companies globally. As a $15B public company (IQV), it operates as the critical infrastructure backbone for pharma R&D and commercialization.
Profile data last refreshed 35m ago · AI intelligence enriched 1mo ago
No open roles listed right now. Follow IQVIA to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from IQVIA's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Help build intelligence for IQVIA
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
iqvia indian pharma market grows 13 yoy to 24 827 cr in august chronic segment surges 16 - ICICI Direct
iqvia indian pharma market grows 13 yoy to 24 827 cr in august chronic segment surges 16 ICICI Direct
Korea’s rare-disease drug market grows nearly fivefold in decade: IQVIA - Korea Biomedical Review
Korea’s rare-disease drug market grows nearly fivefold in decade: IQVIA Korea Biomedical Review
EDA Chairman Discusses Cooperation with IQVIA in Digital Transformation, Artificial Intelligence and Pharmaceutical Data - هيئة الدواء المصرية
EDA Chairman Discusses Cooperation with IQVIA in Digital Transformation, Artificial Intelligence and Pharmaceutical Data هيئة الدواء المصرية
Celltrion’s Steqeyma reaches 16.2% share of US ustekinumab market: IQVIA - Korea Biomedical Review
Celltrion’s Steqeyma reaches 16.2% share of US ustekinumab market: IQVIA Korea Biomedical Review
Q2 Earnings Roundup: IQVIA (NYSE:IQV) And The Rest Of The Drug Development Inputs & Services Segment - finance.yahoo.com
Q2 Earnings Roundup: IQVIA (NYSE:IQV) And The Rest Of The Drug Development Inputs & Services Segment finance.yahoo.com
IQVIA's AI tool cut diabetes screening work by 99.5% and won an award - Stock Titan
IQVIA's AI tool cut diabetes screening work by 99.5% and won an award Stock Titan
Showing 6 of 10 news items
No open positions listed yet. Check their careers page directly.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo